HBOT Conversations:
Elena Schertz & Tom Fox
(Part 5) – COVID
Elena Schetz, NP is the nurse practitioner, and Tom Fox is the Safety Director at Extivita-RTP. Extivita-RTP offers a positive environment for healing, and they encourage anyone seeking a better quality of life to come visit them and experience for themselves the wonder of Hyperbaric Oxygen Therapy.
Watch the Podcast
In a Special 5-part series with Extivita’s Nurse Practitioner, Elena Schertz, and Safety Director, Tom Fox, we dive into the extraordinary powers of HBOT, and the healing they have witnessed for a variety of conditions. The following segments prelude this episode:
Part 1 – HBOT for PTSD (veteran focus)
Part 2 – Concussions & HBOT
Part 3 – Healing Heart Disease with HBOT
Part 4 – Cancer & Cerebral Palsy
In this final episode, we discuss COVID, and how long-haulers are finally finding relief in Hyperbaric Oxygen Therapy.
Host di Girolamo starts the conversation explaining that people who suffer from brain fog, oxygen shortages, and fatigue are discovering that HBOT is providing them relief. Tom chimes in that early oxygen delivery and pre-hospitalization was something the Italians saw in COVID as it progressed, and they discovered the role of HBOT in the acute care stage of COVID. The Italians witnessed patients who were heading in the wrong direction being released from the hospital after only 5 hyperbaric oxygen therapy treatments. The role of hyperbaric oxygen in COVID cases is incredible. Tom reminds us that only about 1,400 of the 6,500 hospital in the US have HBOT chambers, meaning that it is not a standard of care.
Studies out of Britain state ten HBOT treatments are ideal for COVID patients to witness a complete turn-around, and they get their lives back in two weeks. Tom explains that 40% of their patients are long-haul COVID and they’re coming to a HBOT clinic because there’s no other option. Hyperbaric Oxygen Therapy DOES return a COVID patient back to their baseline.
Chronic, or long-haul COVID patients (someone who has been dealing with symptoms for months or years) will likely need more treatments, but there is still so much hope. Elena says that the long-haul COVID patients who have come to see her have all improved. Elena has seen some long-haul COVID patients get better in as little as 4 treatments, and then there are some patients who need 40 treatments. Just like how everyone responds to COVID differently, the same goes for HBOT to treat COVID. There’s no magic number; but if you get in quicker then it’s more likely you won’t need as many treatments. In the end, it’s important to simply know that HBOT hands-down does help COVID patients, and it’s worth a try.
“Elena states, “I want to say it’s kind of easily fixed, you know, the fatigue. I’ve seen it over and over again. Until somebody comes in and disputes that or I see that, then I’ll keep saying, yeah, it really is very effective. I’ve seen it 100% of the time. It really is 100%”
And then there are the vaccine injuries. Tom stresses that he believes in the power of vaccines, he his definitely not an anti-vaxxer. But, when he looks at what’s going on in the world today it’s concerning. If you were to document a vaccine injury right now, it’s almost like the kiss of death to anybody that reaches out to challenge vaccines.
“We’re downplaying the VAER system. You know, in the current vaccine, with the number of reactions that we’ve seen with the current vaccine, previous vaccines would have been taken off the market.
HBOT News appreciates Tom and Elena joining us in our Conversations podcast and invites you to check out their clinic, Extivita-RTP if you are ever in the Raleigh, NC area.
Guests

Elena Schertz, NP - Clinic Manager at Extivita RTP
Elena worked as a nurse in the pediatric oncology, cardiac, and surgical units at UNC hospitals for 15 years before deciding to work in integrative medicine. After years of working as a nurse, she decided to pursue her graduate degree, completing her masters with honors. She is board certified as a Family Nurse Practitioner (FNP) through the American Nurses Credentialing Center.
Elena’s passion for integrative medicine comes from her knowledge that the mind, body and psych/social/spiritual systems are not separate. The focus of Elena’s practice is to approach each of her patient’s healing process from the perspective of the whole, supported and grounded in safety and evidence-based medicine. She also maintains close consultative relationships with experts in the field to promote and enhance wellness for her patients. Elena joined the wonderful Extivita team in March 2019 and is thrilled to be a part of advancing health and wellness through hyperbaric medicine.

Thomas M. Fox, MAS,MS, CHT - Safety Director at Extivita RTP
Tom joined the Extivita team in 2022 as the Safety Director, helping Extivita to maintain a healthy and safe environment for exceptional patient care.
Extivita-RTP – Hyperbaric Oxygen Therapy Clinic
2012-D TW Alexander Drive
Durham, NC 27709
919-354-3775
919-354-3776
contact@extivita.org
https://www.extivita.org/
Subscribe Now, It’s Free!
Recent HBOT News
Clinical Trial – The Effects of Intravenous Dexmedetomidine on Spinal Anesthesia Using Low Dose Diluted Bupivacaine for Transurethral Resection of Prostate
Dexmedetomidine is a new selective and potent alpha-2 agonist. It has centrally acting
anesthetic properties. It has been known that intrathecal addition of alpha-2 adrenergic
agents result in prolongation of the duration of the sensory and motor blockade induced by
hyperbaric bupivacaine. But the effects of intravenous dexmedetomidine on the spinal block
was not evaluated. The aim of study is to assess the effect of intravenous dexmedetomidine on
the low-dose spinal anesthesia for the transurethral surgery.
Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.
Abstract: To analyze the long-term results of a Phase II trial of radiotherapy given immediately after hyperbaric oxygenation (HBO) with multiagent chemotherapy in adults with high-grade gliomas. Patients with histologically confirmed high-grade gliomas were...
Clinical Trial – The Regeneration Effects of Derma-PACE Shockwave in Chronic Diabetic Ulcers
Management of chronic diabetic foot skin ulcers require multidisciplinary approaches
including diabetic control, wound care, antibiotic, shoe wear off-loading, and surgery in
selected cases. The results are inconsistent and irregular, and most studies reported
unsatisfactory results. Many adjunctive therapies are implemented in the care of chronic
diabetic foot ulcers including hyperbaric oxygen therapy (HBO), ultrasound, recombinant human
platelet-derived growth factor-BB (rPDGF-BB), vacuum assisted wound closure (VAWC) and
acellular matrix. HBO is the most commonly utilized at the investigators institution. Mixed
results of HBO in chronic diabetic foot ulcers are reported. Several studies reported that
the beneficial effects of HBO, but none showed universal success. Therefore, the development
of a new effective method of treatment for chronic diabetic ulcers is extremely valuable.
Extracorporeal shockwave therapy (ESWT) acts as mechanotransduction that produces the
therapeutic benefits through complex biological pathways including neovascularization and
tissue regeneration. ESWT also showed bacteriostatic effects in experiments. Some studies
reported the effectiveness of ESWT in acute and chronic soft tissue wounds. Others reported
effectiveness of ESWT in chronic ulcers with 50% completely healed with 6 sessions of
treatment. With this background, it appears that ESWT may be effective in the treatment of
chronic diabetic foot ulcers. The purpose of this study is to evaluate the efficacy of ESWT
in chronic foot ulcers, and to compared with that treated with HBO, and to study the
molecular and blood flow perfusion before and after ESWT.
